Cannabis Sales Remained Pressured in April

New Cannabis Ventures offers readers this easy-to-read exclusive summary of BDSA’s monthly cannabis sales data for 15 states.

Cannabis sales decreased 1.1% sequentially in April, which was an increase on a per-day basis of 2.2%. In this review, we share the results by state, beginning with the western markets and then concluding with the eastern markets. In total, BDSA estimates that sales across the 15 markets totaled $2.13 billion during April, which was up 2.2% from a year ago. Excluding the large gain in New York, which I explain below, sales fell 3.0%.

BDSA provides coverage for Arizona, California, Colorado, Nevada and Oregon. In April, year-over-year growth was negative in all 5 states, with the annual growth rates ranging from -18.9% in California to -2.4% in Oregon. Growth rose sequentially  on a per-day basis in four states.

BDSA provides coverage for Florida, Illinois, Maryland, Massachusetts, Michigan, Missouri, New Jersey, New York, Ohio and Pennsylvania. In April, year-over-year growth ranged from -6.8% in Illinois to +930.7% in New York, which had its adult-use sales included by BDSA for the first time this month (going back to January). Ohio began adult-use in August and was quite high in growth. Note that Florida and Pennsylvania are medical-only markets. Sequential growth was negative  three markets.  The annual growth was meager except in three states. We have been warning about Florida potentially slowing despite the strong growth in dispensaries and in unit volumes due to competitive pressure, and this was the second straight month of declining. The state had never seen a decline until March.

For readers interested in a deeper look at cannabis markets across these fifteen states and more, including segmentation by additional product categories, brand and item detail, longer history, and segmentation by product attributes, learn how BDSA Solutions can provide you with access to actionable data and analysis.